Filter
2411
Filtered Results: 2411
Text search:
drug
regulation
Featured
Recommendations
187
New Publications
664
Language
Document type
No document type
1413
Studies & Reports
409
Guidelines
309
Manuals
120
Strategic & Response Plan
89
Fact sheets
23
Training Material
21
Situation Updates
14
Infographics
5
Brochures
4
Resource Platforms
4
Countries / Regions
India
107
Kenya
87
Global
80
Western and Central Europe
65
Nigeria
57
Uganda
54
South Africa
53
Ethiopia
53
Liberia
43
Sierra Leone
42
Tanzania
42
Ghana
41
Africa
40
Bangladesh
40
Latin America and the Carribbean
39
Nepal
38
Zambia
37
Malawi
33
Eastern Europe
30
Ukraine
28
Myanmar / Burma
28
Philippines
25
Rwanda
24
Namibia
24
Indonesia
24
South–East Asia Region
23
Zimbabwe
19
Asia
18
Lesotho
17
Cambodia
16
Russia
16
Syria
15
Botswana
15
Eswatini/ Swaziland
14
Congo, Democratic Republic of
11
Senegal
10
Pakistan
10
Mozambique
9
Venezuela
9
Thailand
8
Middle East and North Africa
8
Brazil
8
Georgia
8
Cameroon
7
Albania
7
USA
7
Haiti
7
Germany
7
Eastern Europe and Central Asia
7
Vietnam
7
Colombia
6
Burkina Faso
6
West and Central Africa
6
China
5
Laos
5
Western Pacific Region
5
East and Southern Africa
5
Sudan
5
Iraq
5
Tajikistan
4
El Salvador
4
Chile
4
Peru
4
Guinea
4
Argentina
4
Lebanon
4
Moldova
4
South Sudan
4
North Macedonia
3
Mexico
3
Turkey
3
Benin
3
Kyrgyzstan
3
Afghanistan
3
Jordan
3
Paraguay
3
Bolivia
3
Sri Lanka
3
Libya
3
Bhutan
3
Kazakhstan
2
Iran
2
Fiji
2
Uzbekistan
2
Morocco
2
Hungary
2
Portugal
2
Spain
2
Papua New Guinea
2
Yemen
2
Poland
2
Honduras
2
Somalia
2
Switzerland
1
Timor Leste/ East Timor
1
Serbia
1
Australia
1
Singapore
1
Estonia
1
Mongolia
1
Qatar
1
Italy
1
Lithuania
1
Saudi Arabia
1
North America
1
Gabon
1
Uruguay
1
Turkmenistan
1
Jamaica
1
Denmark
1
Belgium
1
France
1
Maldives
1
Mauritius
1
Tunisia
1
United Kingdom
1
Norway
1
Belarus
1
Southern Africa
1
Nicaragua
1
Greece
1
Palestine
1
Central African Republic
1
Mali
1
Angola
1
Ecuador
1
Madagascar
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
962
Clinical Guidelines
163
Public Health
139
Women & Child Health
74
Key Resources
56
Pharmacy & Technologies
46
Capacity Building
22
Toolboxes
Mental Health
245
HIV
224
AMR
197
TB
159
Pharmacy
121
COVID-19
117
Rapid Response
59
NCDs
53
Planetary Health
52
Caregiver
51
NTDs
38
Ebola
35
Global Health Education
32
Refugee
30
Conflict
30
Disability
23
Health Financing Toolbox
16
Specific Hazards
14
Polio
11
Zika
8
Natural Hazards
7
Social Ethics
7
Cholera
5
This primer aims to guide health professionals on engaging with WASH-related issues. It gives an overview of WASH interventions and the status of WASH services globally and outlines key linkages with health. It provides examples of key actions that health actors can take to ensure WASH efforts effec...
The purpose of this document is to present and promote the minimum requirements for IPC programmes at the national and health care facility level, identified by expert consensus according to available evidence and in the context of the WHO core components.
The minimum requirements are defined as: I...
This manual presents a compelling case for action on carbapenem-resistant organisms (CROs) and describes the linkages between the prevention and control of CROs and the Global Action Plan on Antimicrobial Resistance (AMR). It describes how the eight recommendations contained within the World Health ...
Namibia is no exception to the growingglobal concern on the increasing burden of NCDs. Namibia is an upper middle income country with fast economic growth since independence in 1990. The country is bearing the double burden of communicable and noncommunicable diseases and rapid urbanizat...
Sepsis contributes significantly to preventable mortality and is the final common pathway to death for severe infectious diseases; it can also arise as a complication of injuries and non-communicable diseases.
Zoonotic tuberculosis (TB) is a form of TB in people predominantly caused by the bacterial species, Mycobacterium bovis, which belongs to the M. tuberculosis complex. The implications of zoonotic TB go beyond human health. The organism is host-adapted to cattle, where it is refer...
This document aims to provide guidance to healthcare facilities and healthcare providers in the European Union/European Economic Area (EU/EEA) and the United Kingdom (UK) on preparedness and infection prevention and control (IPC) measures for the management of possible and confirmed cases of COVID-1...
Non-pharmaceutical interventions (NPI) are public health measures that aim to prevent and/or control SARS-CoV-2 transmission in the community. As long as there is no effective and safe vaccine to protect those at risk of severe COVID-19, NPI are the most effective public health interventions against...
Applying the evidence of what works from HIV-related stigma and discrimination in six settings to the COVID-19 response
This brief provide evidence-informed guidance to countries on the intersection of stigma related to HIV and COVID-19 in national responses.
The Bolivarian Republic of Venezuela has been facing a sociopolitical and economic situation that has negatively impacted social and health indicators. There have been intensified population movements both within the country and to other countries, particularly to Argentina, Brazil, Chile, Colombia,...
Despite being a curable and preventable disease, tuberculosis (TB) remains as one of the major challenges for health systems, globally. Every year, TB affects more than 10 million people and kills more than 1.4 million people. WHO’s Digital Health for the End TB Strategy – an Agenda for Action o...
Lancet Glob Health 2020Published OnlineNovember 27, 2020 https://doi.org/10.1016/S2214-109X(20)30449-6
The purpose of this guide is to offer recommendations for improving the implementation of non‑pharmacological public health measures during the COVID-19 response and compliance with these measures by population groups in situations of vulnerability. This requires determining the main barriers to i...
BMJ Global Health, Vol.5 No. 12Spatial subdivision of the camp (‘sectoring’) was able to ‘flatten the curve’, reducing peak infection by up to 70% and delaying peak infection by up to several months. The use of face masks coupled with the efficient isolation of infected individuals reduced t...
8 January 2021
Sequencing enabled the world to rapidly identify SARS-CoV-2 and develop diagnostic tests and other tools for outbreak management. Continued genome sequencing supports the monitoring of the disease’s spread and evolution of the virus. Accelerated integration of genome sequencing int...
This guide provides an overview of the major elements that must be considered before, during and after the implementation of antigen-detecting rapid diagnostic tests (Ag-RDTs) for SARS-CoV-2. This guide is complementary to policy guidance issued by the World Health Organization (WHO). The guide may ...
Cognizant of the need for standardization of the response for COVID-19, the Federal Ministry of Health prepared this national guideline in an effort to contain the epidemic before it overwhelms the health care facilities. This national guideline is expected to guide policy makers and h...
.This assessment was conducted using focus group discussion(FGD)with peopleliving with disabilities who were members of the Ethiopian National Association of the Deaf(Person with hearing impairment), Ethiopian National Association of the Deaf -Blind ( Person with hearing and visual impairment), Ethi...
